,96 Remarkably, CEP-1347, a therapeutic agent for chronic liver disease and liver fibrosis, targets RPS5 to inhibit the expression of p70S6K and the activation of hepatic stellate cells, effectively blocking the progression of liver fibrosis.97 The gene discussed is RPS6KB1; the disease is Hepatic fibrosis.